Cargando…
Akute und chronische kardiale Beteiligung bei COVID-19
BACKGROUND: Infections with coronavirus disease 2019 (COVID-19) most frequently affect the lungs but may also result in cardiovascular involvement and cardiovascular complications. The heart can either be involved as part of a systemic infection or directly involved due to myocarditis or pericarditi...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Medizin
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444505/ https://www.ncbi.nlm.nih.gov/pubmed/34529127 http://dx.doi.org/10.1007/s00117-021-00913-4 |
_version_ | 1784568507527069696 |
---|---|
author | Beitzke, Dietrich |
author_facet | Beitzke, Dietrich |
author_sort | Beitzke, Dietrich |
collection | PubMed |
description | BACKGROUND: Infections with coronavirus disease 2019 (COVID-19) most frequently affect the lungs but may also result in cardiovascular involvement and cardiovascular complications. The heart can either be involved as part of a systemic infection or directly involved due to myocarditis or pericarditis as well as in hypoxia, volume overload, fever or thromboembolic complications. Moreover, pre-existing underlying cardiovascular diseases have a substantial influence on the prognosis of patients with COVID-19 infections. METHOD: This review article is based on a comprehensive literature search in the PubMed database on cardiac involvement and cardiac complications of COVID 19 infections, enriched by experiences in dealing with this disorder. RESULTS AND CONCLUSION: Depending on the severity of the infection, cardiac involvement in a COVID 19 infection is observed in up to 50% of the patients. Besides echocardiography as the first-line examination method, cardiac magnetic resonance imaging (MRI) for assessment of the myocardial structure and cardiac computed tomography (CT) for assessment of coronary arteries and to rule out intracardiac thrombus formation represent important imaging modalities. The most important cardiac manifestations in COVID 19 infections are ischemic and inflammatory diseases. The imaging diagnostics play an important role in the acute as well as in the postinfectious phases. |
format | Online Article Text |
id | pubmed-8444505 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Medizin |
record_format | MEDLINE/PubMed |
spelling | pubmed-84445052021-09-17 Akute und chronische kardiale Beteiligung bei COVID-19 Beitzke, Dietrich Radiologe Leitthema BACKGROUND: Infections with coronavirus disease 2019 (COVID-19) most frequently affect the lungs but may also result in cardiovascular involvement and cardiovascular complications. The heart can either be involved as part of a systemic infection or directly involved due to myocarditis or pericarditis as well as in hypoxia, volume overload, fever or thromboembolic complications. Moreover, pre-existing underlying cardiovascular diseases have a substantial influence on the prognosis of patients with COVID-19 infections. METHOD: This review article is based on a comprehensive literature search in the PubMed database on cardiac involvement and cardiac complications of COVID 19 infections, enriched by experiences in dealing with this disorder. RESULTS AND CONCLUSION: Depending on the severity of the infection, cardiac involvement in a COVID 19 infection is observed in up to 50% of the patients. Besides echocardiography as the first-line examination method, cardiac magnetic resonance imaging (MRI) for assessment of the myocardial structure and cardiac computed tomography (CT) for assessment of coronary arteries and to rule out intracardiac thrombus formation represent important imaging modalities. The most important cardiac manifestations in COVID 19 infections are ischemic and inflammatory diseases. The imaging diagnostics play an important role in the acute as well as in the postinfectious phases. Springer Medizin 2021-09-16 2021 /pmc/articles/PMC8444505/ /pubmed/34529127 http://dx.doi.org/10.1007/s00117-021-00913-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access Dieser Artikel wird unter der Creative Commons Namensnennung 4.0 International Lizenz veröffentlicht, welche die Nutzung, Vervielfältigung, Bearbeitung, Verbreitung und Wiedergabe in jeglichem Medium und Format erlaubt, sofern Sie den/die ursprünglichen Autor(en) und die Quelle ordnungsgemäß nennen, einen Link zur Creative Commons Lizenz beifügen und angeben, ob Änderungen vorgenommen wurden. Die in diesem Artikel enthaltenen Bilder und sonstiges Drittmaterial unterliegen ebenfalls der genannten Creative Commons Lizenz, sofern sich aus der Abbildungslegende nichts anderes ergibt. Sofern das betreffende Material nicht unter der genannten Creative Commons Lizenz steht und die betreffende Handlung nicht nach gesetzlichen Vorschriften erlaubt ist, ist für die oben aufgeführten Weiterverwendungen des Materials die Einwilligung des jeweiligen Rechteinhabers einzuholen. Weitere Details zur Lizenz entnehmen Sie bitte der Lizenzinformation auf http://creativecommons.org/licenses/by/4.0/deed.de (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Leitthema Beitzke, Dietrich Akute und chronische kardiale Beteiligung bei COVID-19 |
title | Akute und chronische kardiale Beteiligung bei COVID-19 |
title_full | Akute und chronische kardiale Beteiligung bei COVID-19 |
title_fullStr | Akute und chronische kardiale Beteiligung bei COVID-19 |
title_full_unstemmed | Akute und chronische kardiale Beteiligung bei COVID-19 |
title_short | Akute und chronische kardiale Beteiligung bei COVID-19 |
title_sort | akute und chronische kardiale beteiligung bei covid-19 |
topic | Leitthema |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444505/ https://www.ncbi.nlm.nih.gov/pubmed/34529127 http://dx.doi.org/10.1007/s00117-021-00913-4 |
work_keys_str_mv | AT beitzkedietrich akuteundchronischekardialebeteiligungbeicovid19 |